1,430
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Leucine Rich Repeat Kinase 2: beyond Parkinson’s and beyond kinase inhibitors

, &
Pages 751-753 | Received 24 Mar 2017, Accepted 12 Jun 2017, Published online: 22 Jun 2017
 

Declaration of interest

P. A. Lewis serves as a member of the BBSRC pool of experts, and is a member of the Parkinson’s UK Grant Assessment Panel 1, the Scientific Advisory Panel for Ataxia UK and the Research Strategy Committee of the Multiple Sclerosis Society. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

E.Greggio has received support from the Michael J. Fox Foundation for Parkinson’s Research. S. Cogo is supported by a studentship from the Fondazione CARIPARO and by a fellowship from the Fondazione Aldo Gini. P. A. Lewis has received support from the Medical Research Council [grants MR/N026004/1 and MR/L010933/1], Parkinson’s UK [fellowship F1002], the Biotechnology and Biological Sciences Research Council [CASE studentship BB/M017222/1] and Michael J. Fox Foundation for Parkinson’s Research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.